A drug to treat a deadly cancer in dogs was shown in a clinical trial to extend the survival time of canine patients by 6 months or more, with potential applications in humans. . . . → Read More: Cancer Drug Shown to Improve Survival Time in Dogs
|
|||||
A drug to treat a deadly cancer in dogs was shown in a clinical trial to extend the survival time of canine patients by 6 months or more, with potential applications in humans. . . . → Read More: Cancer Drug Shown to Improve Survival Time in Dogs Ford Motor Company is investing $1 billion in a start-up enterprise that applies artificial intelligence to the operation and management of autonomous vehicles. . . . → Read More: Ford Investing $1B in Artificial Intelligence Start-Up Biotechnology enterprise Immunomedics Inc. is licensing its enhanced antibody-based treatment for solid tumor cancers to Seattle Genetics, a developer of similar cancer drugs. . . . → Read More: Biotechs License Solid Tumor Therapy in $2.1B Deal A small-scale clinical trial shows a combination of four current drugs to treat hypertension, or high blood pressure, formulated in low doses, reduces blood pressure to normal levels in four weeks. . . . → Read More: Low-Dose Multidrug Shown Effective in Hypertension Trial Two universities in the U.K. are developing testing protocols for a new generation of technologies coming to market to prevent mosquitoes from spreading diseases. . . . → Read More: Gates Grant Funding Malaria Control Test Products A biomedical engineering lab developed a compact system that detects harmful bacteria in blood samples in less than four hours, a process that now takes days. . . . → Read More: System Slashes Time to Detect Bacteria in Blood Biomedical engineers developed a technique with unique DNA identifiers that makes possible faster screening of gene therapies delivered with nanoscale particles. . . . → Read More: DNA Tags Speed Nanoparticle Gene Therapy Discovery A clinical trial testing day-to-day use of a smartphone-controlled artificial pancreas for people with type 1 diabetes began enrolling participants. . . . → Read More: Trial Testing Artificial Pancreas for Type 1 Diabetes Researchers at MIT and Harvard University designed a tiny device that in tests with animals show it can run for days powered by acids in the stomach. . . . → Read More: Stomach Acid Harnessed to Power Ingestible Devices Profusa Inc. and a research center at North Carolina State University are developing a new device to monitor tissue oxygen levels in people with peripheral artery disease. . . . → Read More: Company, NC State Partner on Tissue Oxygen Patch |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |